Medical/Pharmaceuticals

A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties

COVID-19 Prevention and Treatment Live-Streaming Training for Rural Doctors Attracted over 1 Million Views HONG KONG, Jan. 20, 2023 /PRNewswire/ -- On January 16, the second stage of "A Healthy Winter Action" initiated by Fosun Foundation in conjunction with other institutions kicked off, with 1...

2023-01-20 18:12 5945

CNN's 'Vital Signs' explores the potential of medical non-invasive therapeutic technology

HONG KONG, Jan. 20, 2023 /PRNewswire/ -- As the search continues for non-invasive ways to treat neurodegenerative diseases, focused ultrasounds have become an alternative to surgery when it comes to treating essential and Parkinson's tremors. This month on CNN's'Vital Signs'

2023-01-20 15:00 4134

VISTA Eye Specialist to host Eye Health Carnival Nationwide in Malaysia

PETALING JAYA, Malaysia, Jan. 20, 2023 /PRNewswire/ -- In an effort to increase eye health awareness for Malaysians, particularly on the top 3 causes of preventable blindness, VISTA Eye Specialist is excited to announce the return of their Eye Health Carnival nationwide, happening mid-February, 2...

2023-01-20 08:00 4001

Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date

IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging. RESTORIN integrates a series of patented technologies fromHarvard University, Mayo Clinic, and Scripps Research to boost cellular nicotinam...

2023-01-19 23:10 6291

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients with Alopecia Areata Strengthens Sun Pharma's Global De...

2023-01-19 23:05 6974

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

LONDON and HONG KONG, Jan. 19, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commi...

2023-01-19 18:56 3922

Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets

Funding from MassMutual Ventures, SEEDS Capital, Exfinity Ventures BOSTON, Jan. 19, 2023 /PRNewswire/ -- Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised$7.5M in a funding round led by MassMutual Ventures, supported by SEEDS Ca...

2023-01-19 08:15 4608

Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications

ROCKVILLE, Md. and SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-01-18 21:34 4900

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing...

2023-01-18 21:00 4304

Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

EAST RUTHERFORD, N.J., Jan. 18, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snap...

2023-01-18 19:00 3885

Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS

Newly merged organization brings together innovative neurodiagnostic and neuromonitoring solutions and experienced teams to offer a broader portfolio of products, services and support to customers worldwide. MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company"...

2023-01-18 18:03 4587

ASG Superconductors and Siemens Healthineers join forces to deliver 10.5T Ultra High Field MRI Systems for ground-breaking brain research

GENOA, Italy, Jan. 18, 2023 /PRNewswire/ -- ASG Superconductors (ASG) and Siemens Healthineers signed a partnership agreement to synergistically develop UHF MRI systems of unprecedented dependability for ground-breaking brain research.

2023-01-18 18:00 4223

WFH Gene Therapy Registry: now live!

MONTREAL, Jan. 18, 2023 /PRNewswire/ -- To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (G...

2023-01-18 18:00 2942

Docquity delivers 10% market share growth for Philippine-based pharmaceutical client in just one year

* Docquity's leading network of HCPs and proprietary Awareness to Advocacy (A2A) solution complemented the Client's Sales and Marketing team to increase conversions in a highly competitive pain product market * Client was able to grow prescriptions and revenue, with over 80% cost savings comp...

2023-01-18 10:00 5102

Boehringer Ingelheim Malaysia Honored As Top Employer For The Fifth Consecutive Year

* Boehringer Ingelheim is one of 15 global Top Employers worldwide  * Achieved Global Recognition and Top Employer Certification in 29  countries From Top Employers Institute® * Outstanding employer benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition...

2023-01-18 09:00 3497

Boehringer Ingelheim Vietnam Honored As Top Employer For The Fourth Consecutive Year

HO CHI MINH CITY, Vietnam, Jan. 18, 2023 /PRNewswire/ -- Boehringer Ingelheim Vietnam has been honored  for the fourth year in succession for its outstanding employee benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition. Globally, Boehringer Ingelheim has ...

2023-01-18 09:00 4430

Mental health focus makes Boehringer Ingelheim stand out as Top Employer 2023 in Asia Pacific for Third Consecutive Year

* Boehringer Ingelheim is one of 15 global Top Employers worldwide * Achieved Global Recognition and Top Employer Certification in 29 countries From Top Employers Institute® * Outstanding employer benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition S...

2023-01-18 09:00 3348

Telix Reports Fourth Quarter 2022 Financial Results

MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- 18 January 2023. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended31 December 2022 (Q4 2022). All figures are in AUD$ ...

2023-01-18 08:50 4003

Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer

SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that it will present t...

2023-01-18 08:00 3447

Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China

Study findings suggest that EVER206 is well-tolerated with no new safety signals, supporting next-phase clinical development inChina SHANGHAI, Jan. 18, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest"), a biopharmaceutical company focused on the development, manufacturing and comm...

2023-01-18 07:30 4795
1 ... 267268269270271272273 ... 381